New Lipid Lowering Therapies for Cardiovascular and Metabolic Diseases: Lessons from the Past and Future Challenges

• Format: eBook
• Language: English
• Published: MDPI - Multidisciplinary Digital Publishing Institute 2019
• Subjects: Biology, life sciences; ABCA1; acute coronary syndrome; acute kidney injury; anacetrapib; apolipoprotein; atherosclerosis; atrial fibrillation; cardiovascular disease; cardiovascular disease (CVD); cardiovascular diseases; cardiovascular risk; ceramides; cholesterol; cholesteryl ester transfer protein; circular RNA; coronary artery bypass grafting; diabetes; dyslipidemia; gene expression; genetic; HDL; hepatic fibrosis; hyperlipidemia; inclisiran; LDL subfractions; lipids; lipoproteins; low-density lipoprotein cholesterol; low-density lipoprotein-cholesterol (LDL-C); miRNA; NAFLD; NASH; nonstatin; NSTEMI; nutrigenetics; PCSK9; pleiotropic actions; proprotein convertase subtilisin-kexin type 9 (PCSK9); proprotein convertase subtilisin/kexin type 9; reverse cholesterol transport; risk stratification; RNA-binding proteins; sdLDL; small interfering RNA (siRNA); sphingolipids; sphingomyelin; statin; statins; STEMI; sterol; stroke; type 2 diabetes; vaspin
• Online Access: Open Access: DOAB: description of the publication; Open Access: DOAB, download the publication
• Physical Description: 1 online resource (116 p.)
• ISBN: 9783039216765; 9783039216772; books978-3-03921-677-2
• Access: Open Access

This book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.